Zscaler chief legal officer Schlossman sells $448,173 in tax-related shares
Source: Investing.com

Zscaler Chief Legal Officer Robert Schlossman sold 2,325 shares worth $448,173 at $192.76 on September 16 solely to cover RSU tax-withholding obligations, retaining direct ownership of 66,919 shares. Zscaler posted fiscal Q4 2026 revenue of $898.2 million, up 25% year over year and 2.4% above consensus, while its stock rose 20% over the past week to $197.47. Multiple firms maintained positive ratings and targets of $200-$225, supported by more than 20% organic ARR growth, a healthy demand outlook, and 77% gross margins.
Analysis
The relevant signal is not the reported equity-sale disclosure: a tax-withholding disposition carries essentially no information content and should not be read as management de-risking. The investable question is whether ZS can sustain billings/ARR growth above the low-20% range while converting its platform expansion into operating leverage; after a sharp one-week move and broad analyst target support, near-term upside is more likely driven by incremental guidance than further rating actions. The market’s risk is that elevated expectations leave little tolerance for a bookings-duration or federal-spending slowdown, even if reported revenue remains resilient.
Competitive read-through favors ZS versus point-product security vendors if enterprise buyers continue consolidating secure web gateway, zero-trust access and data-protection budgets. The less obvious beneficiary is NET, whose security attach can gain from the same architectural migration, while PANW is the principal scaled incumbent capable of using platform pricing to slow ZS seat expansion; CRWD is less directly substitutable but competes for the same CISO budget envelope. Over the next 1-3 months, monitor renewal cohorts, net retention, remaining-performance-obligation growth and large-deal mix rather than headline revenue. A deceleration in those leading indicators would likely compress the growth multiple before consensus EPS estimates adjust; conversely, durable ARR acceleration creates a 6-18 month path to margin-led estimate upside.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.58
Ticker Sentiment
Key Decisions for Investors
- Do not act on the insider filing; treat it as non-discretionary. Maintain a watch alert rather than interpreting it as a bearish management signal.
- Initiate a measured long ZS only on post-results consolidation or a pullback toward $185-$190, with a 3-6 month target of $220-$230 contingent on forward ARR/billings growth holding above 20%. Risk-control: exit if next-quarter forward-looking subscription metrics fall below 18% or management materially increases sales-and-marketing intensity without bookings acceleration.
- For lower beta, express the thesis as long ZS / short PANW in equal dollar risk over 3-6 months. The trade works if zero-trust consolidation remains the purchase priority and ZS sustains growth premium; close if PANW demonstrates material SASE/Prisma access share gains or ZS guides ARR below the 20% threshold.
- Avoid chasing upside calls after the recent rally unless implied volatility normalizes. A defined-risk alternative is a 3-6 month ZS $190/$220 call spread, sized for loss of the full premium; it requires a guidance-driven move rather than merely stable results.
- Use NET and CRWD as read-through monitors, not direct substitutes: broad security-budget strength across all three would support the sector, while ZS-specific weakness amid stable NET/CRWD results would indicate competitive execution rather than macro budget pressure.
More News
- JPMorgan Global Real Estate Head on Hot Markets
- Mara Holdings general counsel Zabi sells $101,349 in stock
- Heartflow Inc stock hits all-time high at 51.78 USD
- Tyson Foods is set to come back on several tailwinds, JPMorgan says
- Why Zscaler Stock Rocketed Higher This Week
- JPMorgan initiates Sigma Lithium stock coverage with overweight rating